CompletedNot applicableNCT05648695

Efficacy of Non-invasive NESA Neuromodulation in Fibromyalgia

Studying NON RARE IN EUROPE: Fibromyalgia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Las Palmas de Gran Canaria
Principal Investigator
Hugo Gómez Garrido, PhD
University of Castilla-La Mancha
Intervention
Non-invasive Neuromodulation(device)
Enrollment
12 target
Eligibility
18 years · All sexes
Timeline
20222023

Study locations (1)

Collaborators

University of Castilla-La Mancha

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05648695 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Fibromyalgia

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Fibromyalgia

← Back to all trials